---
created: 2025-04-13
updated: 2025-04-13T10:53
id: bhXUO;&c#r
specialty: pharmaco
specialty_id: 517
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::13-infectious-disease::03-antibiotics::02-beta-lactams
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::06-cephalosporins
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::06-infectious-disease
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::05-antibiotics::05-cephalosporins
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::01-cell-wall-&-membrane-active-antibiotics::04-cephalosporins::zanki-extra
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^other::^one-by-one"
type: flashcard
---

# Question
Gram-negative cocci coverage of 2nd generation Cephalosporins includes 1st generation (PEcK) as well as HENS   - H**aemophilus influenzae** - E**nterobacter aerogenes** - N**eisseria spp.** - S**erratia marscescens**

---

# Answer
PEcK = Proteus mirabilis, E coli, Klebsiella pneumoniae